Returning guest Dr. Amer Zeidan of Yale Medicine and Smilow Cancer Hospital joins to discuss how clinicians should approach low-risk Myelodysplastic Syndrome (MDS), which is most often managed in community settings. He breaks down how to risk-stratify patients using molecular and prognostic markers, when to treat versus observe, and his preferred first-line therapies in today’s landscape. Dr. Zeidan also delves into the COMMANDS trial and the role of luspatercept, emerging questions shaping t...

Think you can eat your way to a longer, healthier life? Think again. In this episode, I reveal why diets and “superfoods” aren’t enough — and how emotional weight, mindset, and spiritual connection secretly control your energy, aging, and vitality. If you want to thrive — not just survive — this episode will shift the way you think about food, life, and yourself. Thank you for listening. I wish you an amazing aging journey, so I have listed a few resources for you to get you started. Midlife and

Wrapping up our live ESMO 2025 coverage from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review pivotal kidney cancer data, including RAMPART’s results, emerging first-line combinations from KEYMAKER-U03 and more, offering a forward-looking view of where RCC research is heading next.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field

Under the Gel: The Scary Truth About Scanning & The Things They Don’t Warn You About in Ultrasound School. Think ultrasound is all clean gel and pretty pictures? Think again. In this episode, we’re spilling (sometimes literally) the real stories from behind the probe — the smells that make your eyes water, the unexpected bodily fluids that weren’t in the job description, and the “did that really just happen?” moments only a sonographer would understand. From sticky situations to unforgettable

Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review the major ESMO 2025 prostate cancer studies, including ENZARAD, EMBARK, CAPItello-291, PSMAddition, and PR21. Together, they unpack their clinical impact and how evolving biomarkers, imaging, and treatment sequencing are redefining standards of care.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for

Tracey Woodruff breaks down how pollutants, from pesticides to plastics, affect pregnancy and early development. She discusses evolving research on replacement chemicals, the biological mechanisms behind toxic exposure, and the latest findings that alarm (and motivate) scientists today.

Tonight on the Disaster Podcast we dig into the expected impacts Hurricane Melissa will carry into Jamaica as it impacts the island country in the Caribbean. Disaster meteorologist Dan DePodwin and disaster emergency management expert Becky DePodwin join us this evening to look at the storm's origins and projected track.

Welcome to another episode of the more than medical students podcast! We are delighted to discuss a very interesting topic today which is: doing a PhD as a medical student. This is a unique and amazing route for students who are aiming to do research and academia, and not a very common occurrence at med school so we are delighted to be able to bring this route forward and hopefully inspire others who may be interested. Our guest today is Dr Anezka Macey-Dare, who is a newly qualified doctor who took

Petite devinette : Connaissez-vous 1Pulse ? c’est une société spécialisée dans le développement de réseau pour les entrepreneurs… Avec en tête de Gondole le CRC, « Club Réseau conférence » qui se réunit 10 fois par an à Beaune. Parmi les prochains conférenciers attendus : Henri Leconte, Jean Pierre Raffarin, ou encore Denis Brogniart viendront à Beaune dans le cadre du CRC. Le concept avec Romain Perrin, co fondateur de 1 pulse.

Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review ESMO 2025’s bladder cancer headlines, from the evolving role of PD-1/PD-L1 inhibitors to ctDNA-guided adjuvant therapy and antibody-drug conjugates redefining metastatic management.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more

Seekord räägime kopsuvähist. Külas on Tartu Ülikooli Kliinikumi Kopsukliiniku juht, vanemarst-õppejõud ning torakaalkirurgia kaasprofessor Tanel Laisaar. Saatejuht on Ingela Virkus.

In this episode, we look at new research on mucoactive therapy for bronchiectasis, aspirin use in anticoagulated patients with coronary disease, and sotatercept for early pulmonary arterial hypertension. We explore the genetics behind misdiagnosed common diseases and review uncertainty in medical training. We also share a case of woman with abdominal distention, edema, and pleural effusions and Perspectives on sickle cell disease, fetal personhood, and living with a genetic diagnosis.

Nurses Out Loud – An Indiana family secures a major win for parental rights and medical freedom after the state’s Department of Child Services attempts to force vaccinate their children. Attorneys Lindsay Franklin and Michelle Harter join Ashley Grogg to reveal how faith, preparation, and legal action protected a mother’s religious exemption and set a powerful precedent for families nationwide...

The human microbiome, a complex community of bacteria, fungi, protozoa, and viruses, doesn't just passively coexist with the drugs we take; it actively participates in a bidirectional relationship that can impact drug efficacy and toxicity. From immunosuppressants in transplant patients to medicines in other fields of medicine, it is becoming apparent that the microbiome has been a missing piece in our understanding of drug variability, and that it can uniquely impact drug interactions. As this

What is Platelet Rich Fibrin (PRF)?PRF is created from your own blood. Here’s how it works:A small sample of your blood is drawn during your appointment.The sample is placed into a special centrifuge.The machine separates platelets, white blood cells, and fibrin.This concentrated “healing layer” is applied directly to the surgical site.It’s 100% natural because it comes from you, and it jumpstarts your body’s own healing process.Uses of Platelet Rich Fibrin in DentistryIn this episode of The Wonder

In this episode, Evan H. Hirsch, MD speaks with Dr. Jennifer Pfleghaar, DO, to unpack the often-misunderstood transition of perimenopause and how it connects to blood sugar issues, weight gain, GLP-1 medications, and chronic fatigue. Dr. Jen Pfleghaar is a double board-certified physician in Emergency and Integrative Medicine who helps people heal by getting to the root cause. A graduate of Lake Erie College of Osteopathic Medicine and fellowship-trained at the Andrew Weil Center for Integrative

In this rapid-fire Q&A, Woodruff shares her top environmental health concerns for pregnancy and childhood. From phthalates and plastics to practical tips for clinicians, she highlights why even small exposures matter, and how awareness is the first step to prevention.

On today’s episode of The Ultimate Assist, John Stockton and Ken Ruettgers sit down with investigative author Peter A. Kirby, whose explosive new book Chemtrails Exposed: The New Manhattan Project uncovers what he calls the largest covert scientific operation in human history. Kirby traces the hidden evolution of geo-engineering and weather manipulation programs—linking them to intelligence agencies, Cold War technology, and the modern “chemtrail” phenomenon many now see streaking the skies...

#AI #ブログ #音声解説 #NotebookLM

Dialysis in infants with ESKD is often associated with multiple comorbidities and the need for more intensified dialysis regimens. This study found that infant ESKD is associated with significant health care utilization.